Oryzon Genomics S.A. (FRA:ORN)

Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	251	91	115	133	142	210
Market Cap Growth	176.78%	-21.18%	-13.63%	-6.58%	-32.20%	66.16%
Enterprise Value	238	99	121	129	124	180
Last Close Price	3.10	1.50	1.93	2.60	2.62	3.46
PS Ratio	34.08	12.31	8.10	8.48	13.42	22.07
PB Ratio	-	1.04	1.41	1.83	2.00	2.77
P/TBV Ratio	-	1.04	1.41	1.85	2.02	2.78
EV/Sales Ratio	32.31	13.40	8.53	8.19	11.66	18.92
Debt / Equity Ratio	-	0.19	0.22	0.31	0.25	0.18
Asset Turnover	-	0.07	0.14	0.16	0.11	0.11
Inventory Turnover	-	67.11	30.80	8.17	3.55	1.74
Quick Ratio	-	0.74	0.87	1.34	3.75	5.47
Current Ratio	-	0.75	0.87	1.34	3.76	5.51
Return on Equity (ROE)	-	-4.34%	-4.35%	-5.88%	-6.37%	-4.96%
Return on Assets (ROA)	-	-2.61%	-2.71%	-3.45%	-4.63%	-3.08%
Return on Capital (ROIC)	-	-2.77%	-2.92%	-3.74%	-4.92%	-3.27%
Return on Capital Employed (ROCE)	-	-4.60%	-5.00%	-6.50%	-8.10%	-5.00%
Earnings Yield	-1.10%	-4.05%	-2.92%	-3.18%	-3.29%	-1.62%
FCF Yield	-	-6.28%	-0.50%	-1.44%	-2.67%	-2.37%
Buyback Yield / Dilution	-18.64%	-6.35%	-10.10%	-4.80%	-	-15.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.